Brainlabs Planned IPO
The medical technology and software company Brainlab has officially announced that it plans to execute an initial public offering (IPO) on the Prime Standard of the Frankfurt Stock Exchange in the coming weeks. This move is anticipated to be one of the largest stock market events in Germany this year.
Background and Company Profile
- Founding and Development: Stefan Vilsmeier founded Brainlab in 1989. The headquarters is located in Munich, employing around 2,000 staff members. The company specializes in medical software for surgical procedures as well as tumor radiotherapy and is represented in approximately 4,000 healthcare facilities worldwide.
- Corporate Leadership: Vilsmeier will step back from day-to-day operations but will remain involved as a long-term investor.
Details on the Planned IPO
- The IPO will take place on the Prime Standard in the coming weeks. A capital increase will be undertaken to issue new shares, aiming for proceeds of around €600 million and a company valuation of approximately €3 billion.
- The proceeds will be used for business model expansion and strengthening the balance sheet.